Skip to content

Effect of herbs-partitioned moxibustion for primary dysmenorrhea: a factorial design study

Effect of herbs-partitioned moxibustion for primary dysmenorrhea: a factorial design study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022134
Enrollment
Unknown
Registered
2019-03-26
Start date
2019-04-10
Completion date
Unknown
Last updated
2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea

Interventions

qi stagnation and blood stasis syndrome Group C:herb-partition moxibusition (8 cones and 3 days)
qi stagnation and blood stasis syndrome Group D:herb-partition moxibusition (8 cones and 7 days)
Cold coagulation and blood stasis syndrome group A:herb-partition moxibusition (4cones and 3 days)
Cold coagulation and blood stasis syndrome group B:herb-partition moxibusition (4cones and 7 days)
Cold coagulation and blood stasis syndrome group C:herb-partition moxibusition (8 cones and 3 days)
Cold coagulation and blood stasis syndrome group D:herb-partition moxibusition (8 cones and 7 days)
qi stagnation and blood stasis syndrome Group A:herb-partition moxibusition (4cones and 3 days)
qi stagnation and blood stasis syndrome Group B:herb-partition moxibusition (4cones and 7 days)

Sponsors

Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Comform to the diagnostic criteria of primary dysmenorrhea (syndrome of qi stagnation and cold coagulationwith blood stasis); 2. Aged 18 to 35 years; 3. Menstrual cycle (28 + 7) d; 4. Signed informed consent; 5. VAS score = 3; 6. CMSS score >10.

Exclusion criteria

Exclusion criteria: 1. Secondary dysmenorrhea caused by pelvic inflammation, endometriosis,uterine fibroids,ovarian diseases and so on; 2. Severe life-threatening primary diseases of cardiovascular, liver, kidney and blood system, mental illness, women with other diseases who are not suitable for moxibustion; 3. Lactating women and women who are pregnant or are recently prepared for pregnancy; 4. Allergic constitution, or known allergies to the drug ingredients in our study; 5. treatment within 1 months before study,such as massage, acupoint pressing, traditional Chinese medicine, analgesics and hormones; 6. Participants in other clinical trials; 7. Medical workers who participated in the research.

Design outcomes

Primary

MeasureTime frame
Pain intensity;

Secondary

MeasureTime frame
COX menstrual symptom scale;Pain duration;Analgesics usage;Score of WHOQOL-BREF;Serum PGF2a;Serum PGE2;effect of TCM syndromes;

Countries

China

Contacts

Public ContactWang Xin

Affiliated Hospital, Liaoning University of Traditional Chinese Medicine

tmwxtsy@163.com+86 18102456588

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026